| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/13/2011 | US20110008426 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| 01/13/2011 | US20110008425 Treatment for Attention-Deficit Hyperactivity Disorder |
| 01/13/2011 | US20110008424 Sustained Release Solid Formulations and Methods of Manufacturing the Same |
| 01/13/2011 | US20110008423 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
| 01/13/2011 | US20110008422 System for delivery of protein in insoluble fibrillar or aggregate form |
| 01/13/2011 | US20110008421 Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye |
| 01/13/2011 | US20110008420 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/13/2011 | US20110008418 Compositions and Methods for the Treatment of Cancer |
| 01/13/2011 | US20110008417 Immunomodulating compositions and uses therefor |
| 01/13/2011 | US20110008416 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids |
| 01/13/2011 | US20110008415 Novel lipophilic compositions and uses thereof |
| 01/13/2011 | US20110008414 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 01/13/2011 | US20110008413 Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome |
| 01/13/2011 | US20110008412 Oral Formulations for 5-HT-Receptor Agonists, Uses and Methods of Treatment Employing The Same |
| 01/13/2011 | US20110008411 Method of treating pruritis |
| 01/13/2011 | US20110008410 Pharmaceutical composition for treating malaria |
| 01/13/2011 | US20110008409 Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation |
| 01/13/2011 | US20110008404 Modification Of Biomaterials With Microgel Films |
| 01/13/2011 | US20110008402 Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof |
| 01/13/2011 | US20110008398 Medicated patch |
| 01/13/2011 | US20110008397 Compartmental extract compositions for tissue engineering |
| 01/13/2011 | US20110008396 Compositions and methods for treating cardiovascular conditions |
| 01/13/2011 | US20110008395 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof |
| 01/13/2011 | US20110008269 Compositions and Methods Which Modulate G-Protein Signaling for the Treatment of Inflammatory Disorders such as Asthma and Allergic Conjunctivitis |
| 01/13/2011 | US20110008268 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 01/13/2011 | US20110008267 Pharmaceutical and Cosmeceutical Wash-Off Mousse Shampoo Compositions, Processes for Preparing the Same and Uses Thereof |
| 01/13/2011 | US20110008266 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 01/13/2011 | US20110008265 In Situ Polymerization For Hair Treatment |
| 01/13/2011 | US20110008262 Drug delivery system targeting to estrogen receptor over-expressed cells |
| 01/13/2011 | US20110008260 Use of Nanocrystals for Drug Delivery from a Balloon |
| 01/13/2011 | US20110005518 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 01/13/2011 | DE102009031274A1 Liposomen zur pulmonalen Applikation Liposomes for pulmonary administration |
| 01/13/2011 | CA2803282A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767692A1 Pharmaceutical composition for a hepatitis c viral protease inhibitor |
| 01/13/2011 | CA2767646A1 Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| 01/13/2011 | CA2767583A1 Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof |
| 01/13/2011 | CA2767576A1 Pharmaceutical compositions |
| 01/13/2011 | CA2767440A1 Pharmaceutical compositions and solid forms |
| 01/13/2011 | CA2767392A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767342A1 Matrix carrier compositions, methods and uses |
| 01/13/2011 | CA2767251A1 Insulin preparations containing methionine |
| 01/13/2011 | CA2767238A1 Formulations of 6- (5-chloro-2-pyridyl) - 5- [ (4-methyl-1-piperazinyl) carbonyloxy] - 7-0x0-6, 7- dihydro-5h-phyrrolo [3, 4-b] pyrazine |
| 01/13/2011 | CA2767143A1 Tablet having hollow structure |
| 01/13/2011 | CA2766766A1 Method of drug delivery |
| 01/13/2011 | CA2765694A1 Amphoteric liposomes comprising imino lipids |
| 01/13/2011 | CA2764792A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 01/13/2011 | CA2764740A1 Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen |
| 01/12/2011 | EP2272895A1 Vesicles of high molecular weight silicone polyethers |
| 01/12/2011 | EP2272865A2 Method of producing hydroxyalkyl starch derivatives |
| 01/12/2011 | EP2272536A2 Hot-melt extrudable Pharmaceutical formulation |
| 01/12/2011 | EP2272530A2 Antigenic Compositions |
| 01/12/2011 | EP2272526A2 Adjuvant for transcutaneous immunization |
| 01/12/2011 | EP2272519A1 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications |
| 01/12/2011 | EP2272508A2 Pharmaceutical Formulations for Dry Powder Inhalers |
| 01/12/2011 | EP2272507A1 Transdermal formulation comprising an opioid analgesic and an aloe composition |
| 01/12/2011 | EP2272506A2 Microcapsules with modified release of low-solubility active ingredients for oral administration |
| 01/12/2011 | EP2272505A1 Pharmaceutical compositions containing vardenafil hydrochloride trihydrate |
| 01/12/2011 | EP2272504A2 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/12/2011 | EP2272503A2 Oral formulations of cladribine |
| 01/12/2011 | EP2272502A1 Cryogranules of a liquid composition of an allergen product |
| 01/12/2011 | EP2272501A1 Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate |
| 01/12/2011 | EP2272488A1 Vesicle and cosmetic containing the same |
| 01/12/2011 | EP2271612A2 Rasagiline mesylate particles and process for the preparation thereof |
| 01/12/2011 | EP2271401A2 Microcurrent-generating topical or cosmetic systems, and methods of making and using the same |
| 01/12/2011 | EP2271368A1 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery |
| 01/12/2011 | EP2271348A1 Oral and injectable formulations of tetracycline compounds |
| 01/12/2011 | EP2271347A2 Administration of benzodiazepine compositions |
| 01/12/2011 | EP2271325A1 Methods and use of inducing apoptosis in cancer cells |
| 01/12/2011 | EP2271324A2 Encapsulation of biologically active agents |
| 01/12/2011 | EP2271323A2 Encapsulation of biologically active agents |
| 01/12/2011 | EP2271322A2 Encapsulation of biologically active agents |
| 01/12/2011 | EP2271321A1 Pharmaceutical composition 271 |
| 01/12/2011 | EP2271320A1 Raloxifene pharmaceutical formulations |
| 01/12/2011 | EP2271319A1 Formulation with reduced hygroscopicity |
| 01/12/2011 | EP2271318A1 Pharmaceutical depot comprising n-{5- t (cyclopropylamino) carbonyl]-2-methylphenyl}-3-flu0r0-4- (pyridin-2-ylmethox y) benzamide |
| 01/12/2011 | EP2271317A1 Method for manufacturing acid pellets |
| 01/12/2011 | EP2271316A2 Fenofibrate dosage forms |
| 01/12/2011 | EP2271315A2 Novel solid forms of bendamustine hydrochloride |
| 01/12/2011 | EP2271314A2 Compositions and methods for the preparation of nanoemulsions |
| 01/12/2011 | EP2271313A1 Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 01/12/2011 | EP2271312A2 Nerve repair with a hydrogel and optional adhesive |
| 01/12/2011 | EP2271301A2 Methods and compositions for the delivery of agents |
| 01/12/2011 | EP2271214A2 Pharmaceutical solutions and method for solubilizing therapeutic agents |
| 01/12/2011 | EP2271204A2 Dog pheromone formulation and delivery system |
| 01/12/2011 | EP2197554B1 Controlled surface gelling of mucoadhesive polymers on oral mucosa |
| 01/12/2011 | EP2097072B1 Method of producing microcapsules |
| 01/12/2011 | EP2094308B1 Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure |
| 01/12/2011 | EP1938808B1 Preparation for external use comprising tamsulosin |
| 01/12/2011 | EP1814651B1 Process and device for producing finely divided liquid-liquid formulations, and the uses of these liquid-liquid formulations |
| 01/12/2011 | EP1814523B9 Solid, oral drug form which has been designed to prevent misuse |
| 01/12/2011 | EP1638522B1 Solid drug formulation and device for storage and controlled delivery thereof |
| 01/12/2011 | EP1578443B1 Compositions comprising antigen-complexes, method for making same as well as methods of using the antigen-complexes for vaccination |
| 01/12/2011 | EP1523287B1 Materials with both bioadhesive and biodegradable components |
| 01/12/2011 | EP1401458B1 Composition consisting of phy906 and chemotherapeutic agents |
| 01/12/2011 | EP1254951B1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method |
| 01/12/2011 | EP0993829B1 Transdermal preparation containing serotonin receptor antagonist |
| 01/12/2011 | CN201701515U Artemisinine compound suppository for treatment of female genital disease |
| 01/12/2011 | CN201701514U Tablet capsule containing roxithromycin tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN201701513U Tablet capsule filled with cefalexin tablets and ambroxol hydrochloride tablets |